ESP32s are surprisingly good AI lie detectors.

Let’s stop for a moment and pause to consider the smart bulb. Imagine going back 20 years and telling yourself that people ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

INO-3107’s review falls under the purview of Vinay Prasad, M.D., the outgoing director of the Center for Biologics Evaluation and Research who has faced scrutiny for rare disease rejections. (iStock / ...

Baby Keem‘s long-awaited new album, Ca$ino, dropped on Friday and quickly took over the rap discourse online. As one of the first hotly anticipated releases of the ...

GRAMMY Award-winning recording artist Baby Keem has announced The Ca$ino Tour, an extensive 36−date run presented by Live Nation, Eerie Times, and pgLang. The tour ...

Baby Keem is releasing a new album this month. Ca$ino, which follows 2021’s The Melodic Blue, is due out February 20 via pgLang/Eerie Times/Columbia Records and ...

Inovio Pharmaceuticals is highly dependent on the regulatory outcome for INO-3107, its DNA-based therapeutic for recurrent respiratory papillomatosis (RRP). The FDA accepted the BLA for INO-3107 but ...

I believe Inovio Pharmaceuticals’ upside rests almost entirely on INO-3107. The FDA set a standard-review PDUFA for October 30, 2026. INO-3107 targets HPV-6/11 RRP, aiming to reduce repeat surgeries ...

The IRS shut down its direct filing program for 2026, but Free File, Fillable Forms, MilTax, and some private tools remain—if you know where to look. Here’s how to navigate the free options still ...

(NEXSTAR) – In 2025, nearly 300,000 Americans used a new electronic system to file their taxes directly with the IRS for free. In 2026, that’s no longer an option. IRS Direct File launched as a pilot ...

Inovio shares were 22% lower, at $1.80, after the company said the Food and Drug Administration accepted its Biologics License Application for INO-3107 for review as a potential treatment for adults ...